Healthway India Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 26-06-2024
- Paid Up Capital ₹ 3.00 M
as on 26-06-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.00 M
as on 26-06-2024
- Satisfied Charges ₹ 24.60 M
as on 26-06-2024
- Revenue 318.19%
(FY 2022)
- Profit 192.65%
(FY 2022)
- Ebitda 241.55%
(FY 2022)
- Net Worth 19.68%
(FY 2022)
- Total Assets 3.98%
(FY 2022)
About Healthway India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.40 Cr. The company has closed loans amounting to ₹2.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhavan Keerthana, Shanmugasundaram Madhavan, and Gayathrimadhavan serve as directors at the Company.
- CIN/LLPIN
U74900TN2013PTC091433
- Company No.
091433
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Healthway India?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shanmugasundaram Madhavan | Director | 31-May-2013 | Current |
Madhavan Keerthana | Director | Current | |
Gayathrimadhavan | Director | 31-May-2013 | Current |
Financial Performance and Corporate Structure Insights of Healthway India.
Healthway India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 318.19% increase. The company also saw a substantial improvement in profitability, with a 192.65% increase in profit. The company's net worth Soared by an impressive increase of 19.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Healthway India?
In 2021, Healthway India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Agape Lifesciences Private Limited
Active 14 years 10 monthsShanmugasundaram Madhavan and Gayathrimadhavan are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 25 Mar 2022 | ₹1.40 Cr | Open |
Hdfc Bank Limited Creation Date: 07 Feb 2015 | ₹1.85 Cr | Satisfied |
Andhra Bank Creation Date: 08 Jan 2014 | ₹6.10 M | Satisfied |
How Many Employees Work at Healthway India?
Unlock and access historical data on people associated with Healthway India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healthway India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healthway India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.